U.S. Professional Services Stock News

Regulators allowed the Hart Scott Rodino antitrust waiting period for Coterra Energy's merger with Devon Energy to expire, clearing a key hurdle. This approval means Coterra Energy (NYSE:CTRA) can move toward closing, with the company expected to become a wholly owned subsidiary of Devon. The companies currently anticipate closing the transaction in Q2 2026, subject to remaining customary conditions. Coterra Energy focuses on oil and gas exploration and production, an area where scale, cost...

Wix.com (NasdaqGS:WIX) completed a modified Dutch auction share repurchase, buying back nearly 30% of its outstanding shares. The buyback reduces Wix's share count and follows a period of increased focus on AI driven product investments. The transaction comes as some analysts lower their ratings on the stock, even as the company continues to invest in growth initiatives. Wix.com runs a global website creation and business management platform used by individuals, small businesses, and larger...

Executive change triggers fresh look at Ardent Health stock Ardent Health (ARDT) shares are in focus after the company announced that Ethan Chernin, President of Hospital Services, departed on March 24, 2026, under its executive severance plan, prompting investors to reassess leadership stability and valuation. See our latest analysis for Ardent Health. With the latest close at $8.66, Ardent Health has seen a 1 month share price return of 8.26% decline and a 1 year total shareholder return of...

Vontier Corporation recently entered into a 364-day senior unsecured term loan agreement for a US$300 million facility maturing on March 30, 2027, with interest tied to Term SOFR or a base rate plus ratings-based margins, to help repay 2026 senior unsecured notes and fund general corporate purposes. This short-term, unsecured financing underscores lenders’ confidence in Vontier’s credit profile while reshaping its near-term capital structure and liquidity position. We’ll now examine how...

Vaxcyte (PCVX) recently reported full enrollment in its OPUS-1 and OPUS-2 Phase 3 trials for VAX-31, a key step toward a potential Biologics License Application that investors often monitor closely. See our latest analysis for Vaxcyte. The recent completion of enrollment in the OPUS-1 and OPUS-2 trials comes alongside strong momentum, with a 90 day share price return of 25.66% and a 1 year total shareholder return of 84.75%, while the latest share price stands at US$58.38. If this kind of...

In March 2026, Sun Communities’ audit committee replaced Grant Thornton with Deloitte & Touche as its independent auditor for the 2026 fiscal year, while analysts at Mizuho and BMO initiated or reiterated positive coverage highlighting the company’s manufactured housing and RV-focused business. Analysts also pointed to the potential sale of Sun’s UK Parks Holiday business and recent US$457 million of manufactured housing acquisitions as key ways to sharpen the company’s focus on core,...

Minerals Technologies Inc. recently saw analysts upgrade the stock to a Zacks Rank #2 (Buy) on the back of higher earnings estimates, while also confirming its upcoming first-quarter 2026 results release and noting planned retirements of directors Alison A. Deans and Franklin L. Feder after the May 20, 2026 annual meeting. This combination of a more optimistic earnings outlook and forthcoming board turnover highlights how expectations for operating performance are evolving alongside future...

National Presto Industries stock snapshot National Presto Industries (NPK) has quietly put up strong recent returns, with the stock up about 4.5% over the past month and roughly 32% over the past 3 months. See our latest analysis for National Presto Industries. That recent momentum sits on top of a strong longer run, with a 1 year total shareholder return of 73.12% and a 3 year total shareholder return of 117.67%. The share price is now at $141.65 after a 90 day share price return of...

AtriCure recently reported its fourth-quarter 2025 results, highlighting 15% revenue growth that underscored continued demand for its cardiac and pain management devices. The contrast between solid operating performance and more cautious analyst commentary is drawing attention to how market opinion is evolving around AtriCure’s longer-term prospects. We’ll now examine how AtriCure’s strong quarterly revenue performance interacts with shifting analyst sentiment to reshape its existing...

Insiders who purchased US$4.20m worth of Nomadar Corp. ( NASDAQ:NOMA ) shares over the past year recouped some of their...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

TOYO Co., Ltd. ( NASDAQ:TOYO ), might not be a large cap stock, but it led the NASDAQCM gainers with a relatively large...

Disc Medicine (IRON) is back in focus after the FDA issued a Complete Response Letter for its bitopertin program, triggering a 22% one day share price drop and a shareholder rights investigation. See our latest analysis for Disc Medicine. Beyond the sharp reaction to the FDA Complete Response Letter and the shareholder rights investigation, Disc Medicine’s recent 7 day share price return of 8.47% and 30 day share price return of 8.02% sit alongside a 90 day share price return of 17.59% and a...

Amer Sports recently outlined a major 2026 technology push, ramping up IT spending to modernize enterprise systems, digital commerce infrastructure, and data and planning capabilities while embedding AI to streamline operations. This acceleration of digital transformation, underpinned by the rollout of SAP S/4HANA across its brands, could reshape how Amer Sports plans, sells, and fulfills products globally. Next, we’ll examine how Amer Sports’ SAP S/4HANA-driven digital overhaul might...

During March, International Bancshares Corporation’s short interest rose by 24%, climbing from 1,484,699 shares to 1,841,066 shares, marking a clear shift in positioning among traders. This rapid build-up in short positions, occurring even as analyst sentiment remains generally positive, highlights a growing divide between market participants’ expectations. We will examine how this sharp rise in short interest shapes International Bancshares’ investment narrative and what it may signal for...

In March 2026, Flex LNG Ltd. announced a new time charter for the Flex Aurora with a Supermajor, securing a firm two-year term plus optional extensions that could keep the vessel employed through 2034 and lift the company’s total contract backlog to a minimum of 55 years, or up to 82 years if all options are used. This incremental charter backlog adds further revenue visibility at a time when the company has flagged potential revisions to its full-year 2026 guidance amid volatile LNG...

Why Phreesia’s latest guidance cut matters for investors Phreesia (PHR) has drawn fresh attention after issuing lower fiscal 2027 revenue guidance, tying the reset to weaker spending from pharmaceutical clients. The announcement triggered a sharp share price drop and several analyst downgrades. See our latest analysis for Phreesia. The lowered fiscal 2027 revenue outlook, combined with mixed fourth quarter results and analyst downgrades, has sharply shifted sentiment. A 7 day share price...

If you are wondering whether Penguin Solutions is priced attractively right now, the recent share moves give you plenty to think about. The stock last closed at US$20.69, with returns of 24.0% over 7 days, 9.0% over 30 days, 2.0% year to date and 36.2% over 1 year, while the 5 year return sits at a 26.0% decline and the 3 year return at 25.5%. These mixed time frame returns mean recent news flow is important context for understanding what the market is reacting to. Investors looking at...

EACO (EACO) has just posted its Q2 2026 numbers, with recent quarterly revenue running between about US$93.9 million and US$122.5 million and basic EPS ranging from US$1.33 to US$1.95 over the last six reported quarters. Trailing twelve month revenue sits at US$445.0 million and EPS at US$7.13. Over that same trailing period, earnings grew 73.4% year over year and net profit margin reached 7.8% compared with 5.4% a year earlier, setting the backdrop for investors to evaluate how sustainable...

For investors considering whether First Financial Bancorp at about US$28.08 is still good value or starting to look fully priced, this article walks through what the current market price might be implying about the stock. The share price sits around US$28.08, with returns of 3.0% over 7 days, 1.2% over 30 days, 11.9% year to date and 31.9% over the past year. This naturally raises questions about how much of the story is already priced in. Recent news flow around regional banks has kept...

CECO Environmental (NasdaqGS:CECO) has entered into a definitive merger agreement with Thermon Group Holdings. The combined company is expected to focus on industrial mission critical environmental and thermal solutions. The merger is described as a material event that reshapes CECO Environmental's business profile and positioning. For you as an investor, this move links CECO Environmental's air pollution control and fluid handling offerings with Thermon Group's thermal solutions expertise...

Marcus & Millichap (NYSE:MMI) completed the sale of a net-leased childcare facility in Minnesota. The property is leased on a long-term basis to a major early childhood education provider. The transaction adds to recent activity in education focused net-lease real estate. For investors tracking net-lease real estate, this childcare facility sale provides another data point on where capital is moving. Marcus & Millichap, which focuses on commercial real estate brokerage and related services,...

If you are wondering whether F.N.B at US$16.86 is still offering value after its recent run, you are not alone. This article is intended to help you frame that question clearly. The stock has returned 4.2% over the last 7 days, is roughly flat over 30 days with a 0.2% decline, is down 1.9% year to date, and shows a 51.4% return over 1 year, 65.0% over 3 years and 56.4% over 5 years. Recent headlines around F.N.B have kept the stock on investors' radar, adding fresh context to these mixed...